Regulatory Agency Interactions Flashcards
7 cards from real RAC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Regulatory Agency Interactions flashcards as text
What is the purpose of the EMA's PRIME (PRIority MEdicines) scheme?
Answer: To provide early and enhanced support for development of medicines that target unmet medical needs
PRIME provides enhanced early scientific support for medicines that offer a major therapeutic advantage over existing treatments or benefit patients without treatment options.
Which document must be filed with FDA to notify the agency of a change to an approved NDA that has moderate potential to adversely affect product identity, strength, quality, or purity?
Answer: Changes Being Effected in 30 days (CBE-30)
A CBE-30 supplement notifies FDA of a moderate change and can be implemented 30 days after FDA receives the supplement, unless FDA objects.
Under what circumstances can an FDA meeting request be fulfilled by written response only (no teleconference or in-person meeting)?
Answer: When FDA determines that written responses adequately address the issues raised in the meeting request
FDA may determine that written responses are sufficient to address the questions raised, particularly for Type C meetings where the issues are well-defined and can be answered in writing.
What is the role of the Office of Prescription Drug Promotion (OPDP) in FDA regulatory interactions?
Answer: It oversees the regulation of prescription drug promotional materials and advertising
OPDP reviews and regulates prescription drug promotional materials and advertising to ensure they are truthful, balanced, and not misleading.
In a regulatory submission, what is a 'bridging study' typically used to demonstrate?
Answer: That data from one region (e.g., foreign clinical data) can be extrapolated to support approval in a new region
A bridging study generates additional data to allow foreign clinical data to be extrapolated to a new region, demonstrating that regional differences do not affect the benefit-risk profile.
When communicating with regulatory agencies, which principle is considered most critical for maintaining a productive long-term relationship?
Answer: Consistent transparency and proactive disclosure of relevant issues
Transparency and proactive disclosure build regulatory trust; agencies are more likely to work constructively with sponsors who openly share relevant safety or quality issues early.
What is the function of a Regulatory Strategy document in the context of agency interactions?
Answer: It is an internal document outlining the planned regulatory pathway, meeting strategy, and submission timeline to achieve approval
A Regulatory Strategy document is an internal company tool that aligns stakeholders on the regulatory pathway, planned agency interactions, and key milestones needed to achieve marketing authorization.